As of Aug 28
| -0.21 / -0.35%|
The 19 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 71.00, with a high estimate of 80.00 and a low estimate of 55.00. The median estimate represents a +17.14% increase from the last price of 60.61.
The current consensus among 23 polled investment analysts is to Buy stock in Bristol-Myers Squibb. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.